Form 4: Zivo Bioscience Director Christopher D. Maggiore Acquires Shares and Warrants
SEC Form 4 Filing
Director Christopher D. Maggiore reports purchasing shares and warrants of Zivo Bioscience, Inc. on August 22, 2024.
Summary
- On August 22, 2024, Christopher D. Maggiore, a director of Zivo Bioscience, Inc., acquired 31,336 shares of common stock at a price of $8.34 per share.
- Following this transaction, Maggiore directly owns 498,443 shares of Zivo Bioscience.
- Maggiore also acquired 3,133 Common Stock Purchase Warrants with an exercise price of $8.34, exercisable from August 22, 2024, until August 22, 2029.
- After the transaction, Maggiore directly owns 3,133 of these warrants.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as a director is purchasing shares and warrants, indicating confidence in the company. However, it's a single transaction and doesn't provide a comprehensive view.
Positives
- The director's purchase of shares and warrants could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Insider transactions are closely watched by investors as they can provide insights into management's perspective on the company's value and future performance. A purchase by a director is generally viewed positively.
Comparison to Industry Standards
- Comparing Maggiore's transactions to other directors' dealings in similar biotechnology companies could provide context.
- For example, if directors at companies like Algernon Pharmaceuticals Inc. or Lexaria Bioscience Corp. have been actively purchasing shares, it could indicate a broader positive sentiment within the industry.
- Conversely, if sales are more prevalent, it might suggest caution.
Stakeholder Impact
- The purchase could positively influence shareholder sentiment.
- It may also signal to employees that leadership is invested in the company's success.
Key Dates
| Date | Description |
|---|---|
| 08/22/2024 | Date of transaction: purchase of common stock and warrants. |
| 08/22/2029 | Expiration date of the Common Stock Purchase Warrants. |
| 08/23/2024 | Date of signature on the Form 4 filing. |
Keywords
Zivo Bioscience, Christopher D. Maggiore, Form 4, Director, Share Acquisition, Warrant Acquisition, Beneficial Ownership, ZIVO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.